Buy Olumiant (baricitinib) Online

DISEASE INDICATIONS: Rheumatoid Arthritis

MANUFACTURER: Eli Lilly Nederland B.V.

USAGE: Oral

MEDICINE APPROVED BY: European Medical Agency (EMA)

Olumiant (baricitinib) is a prescription medication used to treat rheumatoid arthritis (RA), alopecia areata, and COVID-19. It is a Janus kinase (JAK) inhibitor, which means that it blocks the activity of JAK enzymes. JAK enzymes are involved in the signaling pathway that leads to inflammation.

From $1,070.33

Olumiant (baricitinib) is a prescription medication used to treat:

Moderately to severely active rheumatoid arthritis (RA) in adults who have responded inadequately to, or who are intolerant to one or more disease modifying anti rheumatic drugs (DMARDs).
Alopecia areata (AA) in adults with severe AA who are not candidates for other systemic therapies.
COVID-19 in hospitalized adults requiring supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ECMO).

Olumiant is a Janus kinase (JAK) inhibitor. JAKs are enzymes that play a role in the inflammation and immune response. By blocking JAKs, Olumiant can help to reduce inflammation and improve symptoms of RA, AA, and COVID-19.

How to Use

Olumiant is taken orally once a day. The recommended dose for RA is 2 mg or 4 mg. The recommended dose for AA is 4 mg. The recommended dose for COVID-19 is 4 mg.

Important Safety Information

Olumiant can increase the risk of serious infections, including tuberculosis (TB), shingles, and others caused by bacteria, fungi, or viruses. Before starting Olumiant, your doctor will test you for TB. Olumiant can also reactivate latent TB infection.

Olumiant can also increase the risk of other side effects, such as:

Allergic reactions
Blood clots
Cancer
High cholesterol
High liver enzymes
Low blood counts
Lymphoma
Serious heart problems
Stomach problems
Stroke

Indications

Olumiant is indicated for the treatment of:

Moderately to severely active RA in adults who have responded inadequately to, or who are intolerant to one or more DMARDs.
Severe AA in adults who are not candidates for other systemic therapies.
COVID-19 in hospitalized adults requiring supplemental oxygen, non-invasive or invasive mechanical ventilation, or ECMO.

Precautions

Olumiant should be used with caution in patients with a history of serious infections, TB, blood clots, cancer, high cholesterol, high liver enzymes, low blood counts, lymphoma, heart problems, or stomach problems.

Olumiant should not be used in patients who have a history of severe allergic reactions to Olumiant or other JAK inhibitors.

Interactions

Olumiant may interact with other medications, including live vaccines and other biologic medications. Be sure to tell your doctor about all of the medications you are taking before starting Olumiant.

Contraindications

Olumiant is contraindicated in patients with a history of severe allergic reactions to Olumiant or other JAK inhibitors.

Overdose

There is no known overdose of Olumiant.

Side Effects

The most common side effects of Olumiant are upper respiratory tract infections, headache, diarrhea, nausea, fatigue, and injection site reactions.

More serious side effects of Olumiant include serious infections, blood clots, cancer, high cholesterol, high liver enzymes, low blood counts, lymphoma, heart problems, stomach problems, and stroke.

If you experience any side effects while taking Olumiant, be sure to tell your doctor.

Disclaimer

This information is not intended to be a substitute for professional medical advice. Always talk to your doctor about the risks and benefits of any medication before taking it.